Ozempic and Wegovy – two brand-name semaglutide drugs prescribed for diabetes and weight loss – will lose market exclusivity ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...

Danish drug maker Novo Nordisk is preparing to introduce a new version of its blockbuster drug Ozempic to compete with cheaper generics that became legal on Monday, but which are not expected to hit ...

Health Canada is currently considering nine submissions from other drug companies to make generic semaglutide.

The United States Food and Drug Administration (FDA) has stopped the sale of copycat versions of Ozempic and Wegovy, the Type 2 diabetes drugs used for weight loss. In 2022, the FDA announced there ...

Federal regulators are warning about safety concerns amid the rising popularity of drugs like Ozempic and Wegovy for weight loss. The U.S. Food and Drug Administration is warning consumers that ...

Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." A PAIR OF feet step onto a scale. Then another, and another. A jiggly belly flashes onscreen. “Obesity is ...

With generic versions of the weight-loss drug Ozempic expected to hit the Canadian market this year, provincial data shows ...